Source: Quad-Cities Online
Chad Humphrey chuckled, recalling his brother-in-law sending him fliers for Rogaine, the hair-growth treatment. Mr. Humphrey is married to his high-school sweetheart, Sara, and has three daughters. They, like their ...
Full article at: Quad-Cities Online
More like this 1 day ago, 9:40am CDT
Source: Motley Fool
May isn't in the books yet, but three health-care stocks have shot to the stratosphere. Unsurprisingly, the month's top gainers are all from the biotech space, but not all are small-cap companies. Let's take a moment ...
Full article at: Motley Fool
More like this 1 day ago, 9:24am CDT
Source: Medindia Health News
The rising rates of obesity have increased the risk of nonalcoholic fatty liver disease among teenagers and has also reduced the availability of healthy livers required for organ donations, a new study presented at the Digestive Disease We ...
Full article at: Medindia Health News
More like this 1 day ago, 5:44am CDT
Source: The Hindu
Many pursued their hobbies, watched movies, remained relaxed and yet they were able excel in the examination The climb to the top would have been impossible without the help of family, friends and teachers for many. Many have never burnt the midnight ...
Full article at: The Hindu
More like this 1 day ago, 5:41am CDT
Source: AOL News
After a split vote by a Food and Drug Administration advisory panel, the agency will have the final say on whether Pfizer's (NYS: PFE) tafamidis meglumine is approved in the U.S. The decision won't affect Pfiz ...
Full article at: AOL News
More like this 1 day ago, 5:04pm CDT
Source: American Banking and Market News
Vertex Pharmaceuticals (NASDAQ: VRTX)‘s stock had its “overweight” rating restated by analysts at Barclays Capital (NYSE: BCS) in a research report issued to clients and investors on Friday. A number of other analysts have also recently weighed in on VRT ...
Full article at: American Banking and Market News
More like this 1 day ago, 4:17pm CDT
Source: iStockAnalyst
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Vertex will webcast its presentation at the Sanford C. Bernstein Strategic Decisions Conference on Wednesday, May 30, 2012 at 8:00 a.m. ...
Full article at: iStockAnalyst
More like this 1 day ago, 3:36pm CDT
Source: Mass High Tech Business News
The data may lead to greatly increased numbers of CF patients who could be treated with its approved drug Kalydeco, the company said at the time. Approval of the second CF drug candidate, VX-809, would pos ...
Full article at: Mass High Tech Business News
More like this 1 day ago, 12:37pm CDT
Source: Honda Tuning
The relationship between man and machine can oftentimes be a tumultuous one. If the ends justify the means, then all the bad experiences are worth the struggle. Like every relationship, you’ll oftentimes experience as many highs as you will low ...
Full article at: Honda Tuning
More like this 1 day ago, 12:20pm CDT